ZEPP vs. LTRX, SILC, QMCO, ALOT, INVE, OSS, MKFG, LINK, TACT, and HUBC
Should you be buying Zepp Health stock or one of its competitors? The main competitors of Zepp Health include Lantronix (LTRX), Silicom (SILC), Quantum (QMCO), AstroNova (ALOT), Identiv (INVE), One Stop Systems (OSS), Markforged (MKFG), Interlink Electronics (LINK), TransAct Technologies (TACT), and HUB Cyber Security (HUBC). These companies are all part of the "computer hardware" industry.
Zepp Health vs.
Zepp Health (NYSE:ZEPP) and Lantronix (NASDAQ:LTRX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, media sentiment, risk, community ranking, dividends, profitability and institutional ownership.
Lantronix has lower revenue, but higher earnings than Zepp Health. Lantronix is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks.
Lantronix received 261 more outperform votes than Zepp Health when rated by MarketBeat users. Likewise, 58.63% of users gave Lantronix an outperform vote while only 57.14% of users gave Zepp Health an outperform vote.
Zepp Health has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Comparatively, Lantronix has a beta of 1.94, meaning that its stock price is 94% more volatile than the S&P 500.
Zepp Health currently has a consensus price target of $14.65, suggesting a potential upside of 403.44%. Lantronix has a consensus price target of $6.00, suggesting a potential upside of 106.19%. Given Zepp Health's higher possible upside, research analysts clearly believe Zepp Health is more favorable than Lantronix.
52.6% of Zepp Health shares are held by institutional investors. Comparatively, 39.4% of Lantronix shares are held by institutional investors. 36.0% of Zepp Health shares are held by company insiders. Comparatively, 1.6% of Lantronix shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Lantronix has a net margin of -3.15% compared to Zepp Health's net margin of -19.24%. Lantronix's return on equity of -2.62% beat Zepp Health's return on equity.
In the previous week, Lantronix had 3 more articles in the media than Zepp Health. MarketBeat recorded 5 mentions for Lantronix and 2 mentions for Zepp Health. Zepp Health's average media sentiment score of 0.00 beat Lantronix's score of -0.09 indicating that Zepp Health is being referred to more favorably in the media.
Summary
Lantronix beats Zepp Health on 11 of the 17 factors compared between the two stocks.
Get Zepp Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZEPP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Zepp Health Competitors List
Related Companies and Tools
This page (NYSE:ZEPP) was last updated on 2/22/2025 by MarketBeat.com Staff
